Ads
related to: pulmicort- Dosing & Admin Info
AIRSUPRA: Learn
More About Dosing & Admin.
- Explore Condition Info
Are Your Symptomatic Patients
Looking For An Alternative Option?
- Want To Stay Updated?
Register For News And Updates About
AIRSUPRA Sent To Your Inbox.
- Review AIRSUPRA FAQs
Find Answers To Commonly Asked
Questions About AIRSUPRA.
- Helpful HCP Resources
Help Your Patients Save On AIRSUPRA
& Discover Other Support Resources.
- How AIRSUPRA Is Different
Watch A Video To See How AIRSUPRA
Is Different As A Treatment Option.
- Dosing & Admin Info
Search results
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 3 weeks agoAstraZeneca’s AZN first-quarter 2024 core earnings of $1.03 per American depositary share (ADS) beat...
Will AstraZeneca (AZN) Deliver a Beat This Earnings Season?
Zacks via Yahoo Finance· 2 years agoStrong demand trends for AstraZeneca's (AZN) key drugs, Lynparza, Tagrisso, Imfinzi and Farxiga are...
AstraZeneca (AZN) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoHigher sales of AstraZeneca's (AZN) key medicines, Lynparza, Tagrisso and Imfinzi and Farxiga are...
‘A huge shock to the system’: Doctors warn about asthma inhaler switch coming in January
CNN via Yahoo News· 5 months agoStarting January 1, a drug that thousands of patients depend on to help them breathe will disappear...
What Do Corticosteroids Do and When Do You Need Them?
Health via Yahoo News· 7 months agoCorticosteroids are important, sometimes life-saving therapies and the most widely prescribed drugs...
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 weeks agoImage source: The Motley Fool. AstraZeneca Plc (NASDAQ: AZN) Q1 2024 Earnings Call Apr 25, 2024,...
AstraZeneca (AZN) Q4 Earnings Beat, Sales Hurt by COVID Jab
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN fourth-quarter 2022 core earnings of 69 cents per American depositary share (ADS)...
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
Zacks via Yahoo Finance· 6 months agoAstraZeneca’s AZN third-quarter 2023 core earnings of 87 cents per American depositary share (ADS)...
AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN first-quarter 2023 core earnings of 96 cents per American depositary share (ADS)...
A dispute over a common asthma drug leaves patients caught in the middle
The Hill via Yahoo News· 3 months agoThe most common asthma inhaler for children was discontinued at the start of this year, forcing...